These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 5755918)
1. [Preparation of various N-alkinylated xanthine-derivatives]. Reisch J Arzneimittelforschung; 1968 Nov; 18(11):1485-6. PubMed ID: 5755918 [No Abstract] [Full Text] [Related]
2. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists. Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111 [TBL] [Abstract][Full Text] [Related]
3. [On the synthesis of some methylated bis-xanthines of asymmetric structure]. Gräfe G; Merz KW; Kleine KH Arzneimittelforschung; 1967 Nov; 17(11):1459-61. PubMed ID: 5632169 [No Abstract] [Full Text] [Related]
4. [Synthesis of substituted bis-xanthines]. Kleine KH; Gräfe G; Haller R Arzneimittelforschung; 1969 Nov; 19(11):1854-5. PubMed ID: 5395656 [No Abstract] [Full Text] [Related]
5. THE SEARCH FOR NEW DRUGS IN THE GROUP OF XANTHINE DERIVATIVES. 23. 1-(BETA-HYDROXYPROPYL)-8-BROMOTHEOBROMINE AND ITS DERIVATIVES. ECKSTEIN M; GORCZYCA M Farmaco Sci; 1964 Sep; 19():765-70. PubMed ID: 14200731 [No Abstract] [Full Text] [Related]
6. The search for new drugs in the group of xanthine derivatives. XXVII. 1-(beta-hydroxy-gamma-dialkylaminopropyl) theobromines. Gorczyca M; Eckstein M; Loson W Farmaco Sci; 1966 May; 21(5):338-45. PubMed ID: 5936466 [No Abstract] [Full Text] [Related]
7. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists. Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332 [TBL] [Abstract][Full Text] [Related]
8. Calcium complexes of xanthine derivatives: a new aspect of the mode of action of haemorheologically active drugs. Elben U; Schröer R Arzneimittelforschung; 1984; 34(3):253-5. PubMed ID: 6539604 [TBL] [Abstract][Full Text] [Related]
9. Studies on xanthine derivatives. II. Synthesis of 1,2,3,7-tetrahydro-6H-purin-6-ones from xanthine hydrolyzates. Ohsaki T; Kuriki T; Ueda T; Sakakibara J Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):36-50. PubMed ID: 3698141 [No Abstract] [Full Text] [Related]
10. [Chemistry and synthesis of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine]. Mohler W; Söder A Arzneimittelforschung; 1971 Aug; 21(8):1159-60. PubMed ID: 5110011 [No Abstract] [Full Text] [Related]
11. [SYNTHESIS OF 4-(9'-FLUORENYL)-, 4-(9'-XANTHYL)- AND 4-(BENZHYDRYL)-N-METHYL-4-PIPERIDINOL DERIVATIVES. III. XANTHYL AND BENZHYDRYL DERIVATIVES]. RYLSKI L Acta Pol Pharm; 1963; 20():175-80. PubMed ID: 14061571 [No Abstract] [Full Text] [Related]
12. 1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists. Tabrizi MA; Baraldi PG; Preti D; Romagnoli R; Saponaro G; Baraldi S; Moorman AR; Zaid AN; Varani K; Borea PA Bioorg Med Chem; 2008 Mar; 16(5):2419-30. PubMed ID: 18077171 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonists. Massip S; Guillon J; Bertarelli D; Bosc JJ; Léger JM; Lacher S; Bontemps C; Dupont T; Müller CE; Jarry C Bioorg Med Chem; 2006 Apr; 14(8):2697-719. PubMed ID: 16386423 [TBL] [Abstract][Full Text] [Related]
14. Traceless solid-phase synthesis of substituted xanthines. He R; Ching SM; Lam Y J Comb Chem; 2006; 8(6):923-8. PubMed ID: 17096582 [TBL] [Abstract][Full Text] [Related]
15. [Synthesis of 7-substituted derivatives of 8-aminomethyl-1,3-dimethylxanthine]. Nantka-Namirski P; Jarymowicz B; Wojciechowski J Acta Pol Pharm; 1974; 31(1):5-11. PubMed ID: 4832107 [No Abstract] [Full Text] [Related]
16. [Synthesis of radiosensitizing agents. Part VI. Synthesis of 2,5-dichlorophenacyl alkylxanthates]. Skwarski D; Sobolewski H Acta Pol Pharm; 1992; 49(3):81-4. PubMed ID: 16092419 [TBL] [Abstract][Full Text] [Related]
17. [Synthesis of radiosensitizing agents. Part V. Synthesis of 4-fluoro-3-nitrophenacyl alkylxanthates]. Skwarski D; Sobolewski H Acta Pol Pharm; 1992; 49(3):77-80. PubMed ID: 16092418 [TBL] [Abstract][Full Text] [Related]
18. New and practical method for synthesis of 1- and 1,3-substituted xanthines. Zavialov IA; Dahanukar VH; Nguyen H; Orr C; Zhang F; Andrews DR Org Lett; 2004 Jun; 6(13):2237-40. PubMed ID: 15200329 [TBL] [Abstract][Full Text] [Related]
19. Preparation of 8-substituted xanthine CVT-124 precursor by late stage pyrimidine ring closure. Herr RJ; Vogt PF; Meckler H; Trova MP; Schow SR; Petter RC J Org Chem; 2002 Jan; 67(1):188-93. PubMed ID: 11777458 [TBL] [Abstract][Full Text] [Related]
20. One step syntheses of adenine, xanthine and guanine from phenylazomalonic acid derivatives. Sekiya M; Suzuki J; Terao Y Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1331-5. PubMed ID: 1021289 [No Abstract] [Full Text] [Related] [Next] [New Search]